4/13/2010

The FDA approved Pancreaze for use in patients with cystic fibrosis and other conditions caused by pancreatic-enzyme deficiency. The treatment, developed by Johnson & Johnson, will compete with pancreatic-enzyme products from Eurand and Abbott Laboratories.

Full Story:
Reuters

Related Summaries